These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 25736313)
1. Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML. Rijal S; Fleming S; Cummings N; Rynkiewicz NK; Ooms LM; Nguyen NY; Teh TC; Avery S; McManus JF; Papenfuss AT; McLean C; Guthridge MA; Mitchell CA; Wei AH Blood; 2015 Apr; 125(18):2815-24. PubMed ID: 25736313 [TBL] [Abstract][Full Text] [Related]
2. INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia. Dzneladze I; He R; Woolley JF; Son MH; Sharobim MH; Greenberg SA; Gabra M; Langlois C; Rashid A; Hakem A; Ibrahimova N; Arruda A; Löwenberg B; Valk PJ; Minden MD; Salmena L Leukemia; 2015 Jul; 29(7):1485-95. PubMed ID: 25736236 [TBL] [Abstract][Full Text] [Related]
3. The INPP4B paradox: Like PTEN, but different. Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856 [TBL] [Abstract][Full Text] [Related]
4. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases. Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369 [TBL] [Abstract][Full Text] [Related]
5. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia. Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273 [TBL] [Abstract][Full Text] [Related]
6. INPP4B, a new player in the chemoresistance of AML. Recher C Blood; 2015 Apr; 125(18):2738-9. PubMed ID: 25931577 [No Abstract] [Full Text] [Related]
7. INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia. Wang P; Ma D; Wang J; Fang Q; Gao R; Wu W; Cao L; Hu X; Zhao J; Li Y Tumour Biol; 2016 Sep; 37(9):12513-12523. PubMed ID: 27342972 [TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide phosphatases: just as important as the kinases. Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078 [TBL] [Abstract][Full Text] [Related]
9. Investigating the multifaceted cooperation of autophagy, PI3K/AKT signaling pathways, and INPP4B gene in de novo acute myeloid leukemia patients. Gorji M; Farsani MA; Kargar M; Garavand J; Mohammadi MH Curr Res Transl Med; 2024 Jun; 72(2):103429. PubMed ID: 38246071 [TBL] [Abstract][Full Text] [Related]
10. INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor. Kofuji S; Kimura H; Nakanishi H; Nanjo H; Takasuga S; Liu H; Eguchi S; Nakamura R; Itoh R; Ueno N; Asanuma K; Huang M; Koizumi A; Habuchi T; Yamazaki M; Suzuki A; Sasaki J; Sasaki T Cancer Discov; 2015 Jul; 5(7):730-9. PubMed ID: 25883023 [TBL] [Abstract][Full Text] [Related]
11. IRF2-INPP4B axis participates in the development of acute myeloid leukemia by regulating cell growth and survival. Zhang F; Zhu J; Li J; Zhu F; Zhang P Gene; 2017 Sep; 627():9-14. PubMed ID: 28579269 [TBL] [Abstract][Full Text] [Related]
12. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases. Eramo MJ; Mitchell CA Biochem Soc Trans; 2016 Feb; 44(1):240-52. PubMed ID: 26862211 [TBL] [Abstract][Full Text] [Related]
13. Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities. Lopez SM; Hodgson MC; Packianathan C; Bingol-Ozakpinar O; Uras F; Rosen BP; Agoulnik IU Biochem Biophys Res Commun; 2013 Oct; 440(2):277-82. PubMed ID: 24070612 [TBL] [Abstract][Full Text] [Related]
14. IRF2-INPP4B-mediated autophagy suppresses apoptosis in acute myeloid leukemia cells. Zhang F; Li J; Zhu J; Liu L; Zhu K; Cheng S; Lv R; Zhang P Biol Res; 2019 Mar; 52(1):11. PubMed ID: 30876449 [TBL] [Abstract][Full Text] [Related]
15. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles. Déléris P; Bacqueville D; Gayral S; Carrez L; Salles JP; Perret B; Breton-Douillon M J Biol Chem; 2003 Oct; 278(40):38884-91. PubMed ID: 12847108 [TBL] [Abstract][Full Text] [Related]
16. The inositol polyphosphate 5-phosphatase, PIPP, Is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation. Ooms LM; Fedele CG; Astle MV; Ivetac I; Cheung V; Pearson RB; Layton MJ; Forrai A; Nandurkar HH; Mitchell CA Mol Biol Cell; 2006 Feb; 17(2):607-22. PubMed ID: 16280363 [TBL] [Abstract][Full Text] [Related]
17. SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML. Dzneladze I; Woolley JF; Rossell C; Han Y; Rashid A; Jain M; Reimand J; Minden MD; Salmena L PLoS One; 2018; 13(2):e0191510. PubMed ID: 29415082 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of lipid kinase PIKfyve reveals a role for phosphatase Inpp4b in the regulation of PI(3)P-mediated lysosome dynamics through VPS34 activity. Saffi GT; Wang CA; Mangialardi EM; Vacher J; Botelho RJ; Salmena L J Biol Chem; 2022 Aug; 298(8):102187. PubMed ID: 35760104 [TBL] [Abstract][Full Text] [Related]
19. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC. Reed DE; Shokat KM Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852 [TBL] [Abstract][Full Text] [Related]
20. INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells. Min JW; Kim KI; Kim HA; Kim EK; Noh WC; Jeon HB; Cho DH; Oh JS; Park IC; Hwang SG; Kim JS Biochem Biophys Res Commun; 2013 Oct; 440(1):137-42. PubMed ID: 24051093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]